Kilitch Drugs (India) Ltd Q3 FY2023-2024 Results: Summary

Revenue
₹34.75Cr
Net Profits
₹2.91Cr
Net Profit Margins
8.37%

Highlights

Revenue:

Kilitch Drugs (India) Ltd’s revenue jumped 13.34% since last year same period to ₹34.75Cr in the Q3 2023-2024. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -16.65% fall in its revenue since last 3-months.

Net Profits:

Kilitch Drugs (India) Ltd’s net profit jumped 22.78% since last year same period to ₹2.91Cr in the Q3 2023-2024. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -38.61% fall in its net profits since last 3-months.

Net Profit Margins:

Kilitch Drugs (India) Ltd’s net profit margin jumped 8.33% since last year same period to 8.37% in the Q3 2023-2024. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -26.35% fall in its net profit margins since last 3-months.

FAQs

The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2023 was ₹34.75Cr.

The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2023 was ₹2.91Cr.

The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2023 was 8.37%.

The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2022 was ₹30.66Cr.

The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2022 was ₹2.37Cr.

The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2022 was 7.73%.